000			02064 a2200529 4500
005			20250516132104.0
264		0	_c20130516
008			201305s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2012-10-460832 _2doi
040			_aNLM _beng _cNLM
100	1		_aIyengar, Sunil
245	0	0	_aP110α-mediated constitutive PI3K signaling limits the efficacy of p110δ-selective inhibition in mantle cell lymphoma, particularly with multiple relapse. _h[electronic resource]
260			_bBlood _cMar 2013
300			_a2274-84 p. _bdigital
500			_aPublication Type: Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology
650	0	4	_aCell Line, Tumor
650	0	4	_aClass I Phosphatidylinositol 3-Kinases
650	0	4	_aDNA Mutational Analysis
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aGene Expression Regulation, Enzymologic _xphysiology
650	0	4	_aGene Expression Regulation, Neoplastic _xdrug effects
650	0	4	_aHumans
650	0	4	_aLymphoma, Mantle-Cell _xdrug therapy
650	0	4	_aPhosphatidylinositol 3-Kinases _xgenetics
650	0	4	_aPhosphoinositide-3 Kinase Inhibitors
650	0	4	_aProtein Kinase Inhibitors _xadministration & dosage
650	0	4	_aPurines _xadministration & dosage
650	0	4	_aQuinazolinones _xadministration & dosage
650	0	4	_aRecurrence
650	0	4	_aSignal Transduction _xphysiology
650	0	4	_aSubstrate Specificity
650	0	4	_aTreatment Outcome
700	1		_aClear, Andrew
700	1		_aBödör, Csaba
700	1		_aMaharaj, Lenushka
700	1		_aLee, Abigail
700	1		_aCalaminici, Maria
700	1		_aMatthews, Janet
700	1		_aIqbal, Sameena
700	1		_aAuer, Rebecca
700	1		_aGribben, John
700	1		_aJoel, Simon
773	0		_tBlood _gvol. 121 _gno. 12 _gp. 2274-84
856	4	0	_uhttps://doi.org/10.1182/blood-2012-10-460832 _zAvailable from publisher's website
999			_c22440001 _d22440001